nolan-full-background-stanford
ASSESSMENT dossier

Garry Nolan (Full Background: Stanford Professor, 350+ Papers, 50 Patents, 7+ Biotech Companies, David Baltimore Trainee)

ASSESSMENT ASSESSMENT // NOLAN FULL BACKGROUND Also: Garry Nolan, Nolan Stanford professor, Nolan 350 papers, Nolan 50 patents, Nolan David Baltimore trainee, Nolan Sol Foundation co-founder, Nolan biotech entrepreneur, Nolan CyTOF CODEX MIBI, Nolan Rigel Nodality BINA, Nolan Parker Institute, Nolan UAP brain damage

01 Executive_Summary

ASSESSMENT: Garry Philip James Nolan (born 1961, British-American) is the SCIENTIFIC TITAN of the UAP movement — Stanford professor with extraordinary mainstream credentials who pivoted to UAP research. Rachford and Carlota A. Harris Professor, Dept. of Pathology, Stanford University School of Medicine. EDUCATION: BS Biology (genetics), Cornell 1983. PhD Genetics, Stanford 1989 (under Leonard Herzenberg). Postdoc: Nobel laureate David Baltimore, MIT 1990-1993 ('first cloning/characterization of NF-kB p65/RelA' + 'rapid retroviral production systems'). CAREER: 1993 Assistant Prof Stanford. 1999 Associate. 2009 Professor. 2011 Harris Professor (endowed chair). Research: autoimmunity, inflammation, cancer/leukemia, hematopoiesis, computation for network/systems immunology. PUBLICATIONS: 350+ research articles (most top-tier journals). PATENTS: 40-50 US patents. 'One of top 25 inventors at Stanford.' AWARDS: Teal Innovator Award (2012) DoD $3.3M ovarian cancer. First FDA BAAA 'Bio-agent protection' $3M 'Cross-Species Immune System Reference.' Nature Publishing Group 'Outstanding Research Achievement 2011' (CyTOF). $3.5M FDA Ebola field platforms Africa. FDA Zika/Ebola grant. Member Parker Institute for Cancer Immunotherapy. BIOTECH COMPANIES FOUNDED: Rigel Inc. (NASDAQ: RIGL), Nodality (diagnostics), BINA (genomics, sold to Roche), Apprise (sold to Roche), Ionpath (co-founder), Akoya (co-founder), Scale Bio (co-founder). DVS Sciences (SAB Chair, sold to Fluidigm $207M 2014). TECHNOLOGY: CyTOF (cytometry by time-of-flight), CODEX + MIBI (deep tissue profiling). 'Contributed fundamentally to Human Cell Atlas and cancer cell atlases worldwide.' UAP WORK: Sol Foundation co-founder + Executive Director of Board. UAP materials testing (Ubatuba, Council Bluffs) with secondary ion mass spectrometry. Brain damage research on UAP witnesses + Havana Syndrome. Stanford 2023 Symposium organizer. 'Since 2022, most public appearances related to ufology and belief that ET intelligence has visited or resides on Earth.' CRITICAL: David Baltimore trainee = highest pedigree. 350+ papers + 50 patents = extraordinary productivity. 7+ biotech companies = commercial impact. DoD + FDA grants = government trust. Ebola field platforms = biodefense. CyTOF/CODEX/MIBI = cutting-edge for UAP biology. Top 25 Stanford inventors. Parker Institute = tech billionaire network. Pivot to UAP since 2022 = deliberate career decision.

03 Deep_Dive_Intelligence

Overview

ASSESSMENT: Garry Philip James Nolan (born 1961, British-American) is the SCIENTIFIC TITAN of the UAP movement — Stanford professor with extraordinary mainstream credentials who pivoted to UAP research. Rachford and Carlota A. Harris Professor, Dept. of Pathology, Stanford University School of Medicine. EDUCATION: BS Biology (genetics), Cornell 1983. PhD Genetics, Stanford 1989 (under Leonard Herzenberg). Postdoc: Nobel laureate David Baltimore, MIT 1990-1993 ('first cloning/characterization of NF-kB p65/RelA' + 'rapid retroviral production systems'). CAREER: 1993 Assistant Prof Stanford. 1999 Associate. 2009 Professor. 2011 Harris Professor (endowed chair). Research: autoimmunity, inflammation, cancer/leukemia, hematopoiesis, computation for network/systems immunology. PUBLICATIONS: 350+ research articles (most top-tier journals). PATENTS: 40-50 US patents. 'One of top 25 inventors at Stanford.' AWARDS: Teal Innovator Award (2012) DoD $3.3M ovarian cancer. First FDA BAAA 'Bio-agent protection' $3M 'Cross-Species Immune System Reference.' Nature Publishing Group 'Outstanding Research Achievement 2011' (CyTOF). $3.5M FDA Ebola field platforms Africa. FDA Zika/Ebola grant. Member Parker Institute for Cancer Immunotherapy. BIOTECH COMPANIES FOUNDED: Rigel Inc. (NASDAQ: RIGL), Nodality (diagnostics), BINA (genomics, sold to Roche), Apprise (sold to Roche), Ionpath (co-founder), Akoya (co-founder), Scale Bio (co-founder). DVS Sciences (SAB Chair, sold to Fluidigm $207M 2014). TECHNOLOGY: CyTOF (cytometry by time-of-flight), CODEX + MIBI (deep tissue profiling). 'Contributed fundamentally to Human Cell Atlas and cancer cell atlases worldwide.' UAP WORK: Sol Foundation co-founder + Executive Director of Board. UAP materials testing (Ubatuba, Council Bluffs) with secondary ion mass spectrometry. Brain damage research on UAP witnesses + Havana Syndrome. Stanford 2023 Symposium organizer. 'Since 2022, most public appearances related to ufology and belief that ET intelligence has visited or resides on Earth.' CRITICAL: David Baltimore trainee = highest pedigree. 350+ papers + 50 patents = extraordinary productivity. 7+ biotech companies = commercial impact. DoD + FDA grants = government trust. Ebola field platforms = biodefense. CyTOF/CODEX/MIBI = cutting-edge for UAP biology. Top 25 Stanford inventors. Parker Institute = tech billionaire network. Pivot to UAP since 2022 = deliberate career decision.

Entity Type: Assessment — Garry Nolan (Full Background: Stanford Professor, 350+ Papers, 50 Patents, 7+ Biotech Companies, David Baltimore Trainee) is an analytical assessment synthesizing multiple data points.

Source Documents

Intelligence derived from 5 source documents:

  • thesolfoundation.org — Garry Nolan
  • en.wikipedia.org — Garry Nolan
  • profiles.stanford.edu — Garry Nolan
  • med.stanford.edu — Garry Nolan
  • cap.stanford.edu — Garry Nolan full profile

07 Key_Findings

  • ▸ Entity Type: Assessment — Garry Nolan (Full Background: Stanford Professor, 350+ Papers, 50 Patents, 7+ Biotech Companies, David Baltimore Trainee) is an analytical assessment synthesizing multiple data points.
  • ▸ thesolfoundation.org — Garry Nolan
  • ▸ profiles.stanford.edu — Garry Nolan
  • ▸ cap.stanford.edu — Garry Nolan full profile

09 Timeline_Mentions (8)

1993

Garry Nolan (1993-2026): Stanford professor, 350+ papers, 50 patents, 7+ biotech companies, David Baltimore trainee, Sol Foundation co-founder

Stanford professor. 350+ papers. 50 patents. Top 25 Stanford inventors. David Baltimore trainee. 7+ biotech companies. DoD/FDA grants. CyTOF/CODEX/MIBI. Sol Foundation. UAP materials + brain damage.

uap-research
2023

Sol Foundation launched (Aug 2023) — Stanford UAP think tank: Nolan + Grusch + Davis + McCullough (former IC IG)

Stanford UAP think tank. Nolan (brain damage), Grusch (whistleblower COO), Davis (AAWSAP), McCullough (former IC IG legal counsel), Gallaudet, Loeb, Vallée. Academic arm.

uap-research
2023

Nolan co-founds Sol Foundation (Aug 2023) + tests UAP materials at Stanford — Ubatuba, Council Bluffs, brain damage research

Stanford professor co-founds Sol with Skafish + Grusch. 350+ papers, 40 patents. Tests UAP materials with Vallée (secondary ion mass spec). Ubatuba, Council Bluffs. Brain damage ~100 personnel.

uap-research
2023

Berte co-founds Sol Foundation (Aug 2023): Robovision AI entrepreneur brings computer vision to UAP research + Disclosure Foundation CTO

Robovision founder (1,000+ AI deployments, $200-300M revenue). Sol co-founder. Disclosure Foundation CTO. Computer vision = UAP image analysis. ETH Zürich + Ghent.

uap-research
2023

Ryan Graves testimony (July 2023): first active-duty pilot to go public, Americans for Safe Aerospace (5,000 members), AIAA UAP committee (80 PhDs)

F-18 pilot. First to go public. Americans for Safe Aerospace (5,000 members, 30+ witnesses). AIAA UAP committee chair (80 PhDs). NARCAP. BAE FAST Labs. 'Regular sightings' over decade.

uap-research
2024

NSF convergence meeting (Nov 2024) — Chase (RTP/fusion) + Puthoff (AAWSAP/UAP) + Nolan (brain damage) at same event

120+ experts. Chase + Puthoff + Nolan + Graves + Stratton. The convergence of classified fusion/plasma development and UAP research. Steve Justice (Skunk Works) co-founded TTSA with Puthoff.

uap-research
2024

Sol Foundation 2024 Symposium (Nov 22-23): Nell+Davis+Gallaudet+Graves+Mellon+Loeb+Vallée — Stanford-sponsored, sold out

Most comprehensive academic UAP conference. 17+ speakers. Nell+Nolan NHI framework. Davis+McConnell executive secrecy. Gallaudet all-of-government. Loeb Galileo Project. Stanford sponsored.

uap-research
2025

Nolan (Stanford) links UAP to brain damage — white matter disease in ~100 government personnel, RF/plasma connection

~100 patients with white matter disease. Government/aerospace personnel. Havana syndrome + UAP encounters. 'Pulsed RF energy weapon' line of inquiry. Plasma connection.

uap-research
View Full Timeline →

10 FAQ

What is Garry Nolan (Full Background: Stanford Professor, 350+ Papers, 50 Patents, 7+ Biotech Companies, David Baltimore Trainee)? ▾
ASSESSMENT: Garry Philip James Nolan (born 1961, British-American) is the SCIENTIFIC TITAN of the UAP movement — Stanford professor with extraordinary mainstream credentials who pivoted to UAP research. Rachford and Carlota A. Harris Professor, Dept. of Pathology, Stanford University School of Medicine. EDUCATION: BS Biology (genetics), Cornell 1983. PhD Genetics, Stanford 1989 (under Leonard Herzenberg). Postdoc: Nobel laureate David Baltimore, MIT 1990-1993 ('first cloning/characterization of NF-kB p65/RelA' + 'rapid retroviral production systems'). CAREER: 1993 Assistant Prof Stanford. 1999 Associate. 2009 Professor. 2011 Harris Professor (endowed chair). Research: autoimmunity, inflammation, cancer/leukemia, hematopoiesis, computation for network/systems immunology. PUBLICATIONS: 350+ research articles (most top-tier journals). PATENTS: 40-50 US patents. 'One of top 25 inventors at Stanford.' AWARDS: Teal Innovator Award (2012) DoD $3.3M ovarian cancer. First FDA BAAA 'Bio-agent protection' $3M 'Cross-Species Immune System Reference.' Nature Publishing Group 'Outstanding Research Achievement 2011' (CyTOF). $3.5M FDA Ebola field platforms Africa. FDA Zika/Ebola grant. Member Parker Institute for Cancer Immunotherapy. BIOTECH COMPANIES FOUNDED: Rigel Inc. (NASDAQ: RIGL), Nodality (diagnostics), BINA (genomics, sold to Roche), Apprise (sold to Roche), Ionpath (co-founder), Akoya (co-founder), Scale Bio (co-founder). DVS Sciences (SAB Chair, sold to Fluidigm $207M 2014). TECHNOLOGY: CyTOF (cytometry by time-of-flight), CODEX + MIBI (deep tissue profiling). 'Contributed fundamentally to Human Cell Atlas and cancer cell atlases worldwide.' UAP WORK: Sol Foundation co-founder + Executive Director of Board. UAP materials testing (Ubatuba, Council Bluffs) with secondary ion mass spectrometry. Brain damage research on UAP witnesses + Havana Syndrome. Stanford 2023 Symposium organizer. 'Since 2022, most public appearances related to ufology and belief that ET intelligence has visited or resides on Earth.' CRITICAL: David Baltimore trainee = highest pedigree. 350+ papers + 50 patents = extraordinary productivity. 7+ biotech companies = commercial impact. DoD + FDA grants = government trust. Ebola field platforms = biodefense. CyTOF/CODEX/MIBI = cutting-edge for UAP biology. Top 25 Stanford inventors. Parker Institute = tech billionaire network. Pivot to UAP since 2022 = deliberate career decision.
When did Garry Nolan (Full Background: Stanford Professor, 350+ Papers, 50 Patents, 7+ Biotech Companies, David Baltimore Trainee) appear in the research timeline? ▾
Garry Nolan (Full Background: Stanford Professor, 350+ Papers, 50 Patents, 7+ Biotech Companies, David Baltimore Trainee) is referenced in 8 timeline events, including "Garry Nolan (1993-2026): Stanford professor, 350+ papers, 50 patents, 7+ biotech companies, David Baltimore trainee, Sol Foundation co-founder" (1993). The full timeline provides chronological context for all documented activities.
What source documents are available for Garry Nolan (Full Background: Stanford Professor, 350+ Papers, 50 Patents, 7+ Biotech Companies, David Baltimore Trainee)? ▾
5 source documents are available in the research archive, including primary source PDFs from defense research collections. These documents provide the evidentiary basis for the intelligence assessment.
What does the deep dive analysis reveal about Garry Nolan (Full Background: Stanford Professor, 350+ Papers, 50 Patents, 7+ Biotech Companies, David Baltimore Trainee)? ▾
The deep dive intelligence assessment provides a comprehensive analysis of Garry Nolan (Full Background: Stanford Professor, 350+ Papers, 50 Patents, 7+ Biotech Companies, David Baltimore Trainee), covering strategic role, network connections, and operational significance. The analysis is derived from 5 primary source documents and cross-referenced with the network graph.

Source_Documents 5 FILES

thesolfoundation.org — Garry Nolan
PDF Archive →
en.wikipedia.org — Garry Nolan
PDF Archive →
profiles.stanford.edu — Garry Nolan
PDF Archive →
med.stanford.edu — Garry Nolan
PDF Archive →
cap.stanford.edu — Garry Nolan full profile
PDF Archive →

External_References 5 REFS

thesolfoundation.org — Garry Nolan url ↗
en.wikipedia.org — Garry Nolan ref
profiles.stanford.edu — Garry Nolan ref
med.stanford.edu — Garry Nolan ref
cap.stanford.edu — Garry Nolan full profile ref
← Back to Dossiers
ID: nolan-full-background-stanford
Type: assessment
Region: intel-base
Last updated: 2026-08-09